{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:29:40Z","timestamp":1786994980298,"version":"build-2736575974"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroimaging Clinics of North America"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.nic.2024.12.002","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T07:25:09Z","timestamp":1739949909000},"page":"267-275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Altered Clearance and Amyloid-Related Imaging Abnormalities"],"prefix":"10.1016","volume":"35","author":[{"given":"Petrice M.","family":"Cogswell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"Burkett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek R.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay J.","family":"Pillai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.nic.2024.12.002_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","article-title":"National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease","volume":"8","author":"Hyman","year":"2012","journal-title":"Alzheimers Dement"},{"issue":"4","key":"10.1016\/j.nic.2024.12.002_bib2","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"9","key":"10.1016\/j.nic.2024.12.002_bib3","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/nrd3505","article-title":"The amyloid cascade hypothesis for Alzheimer\u2019s disease: an appraisal for the development of therapeutics","volume":"10","author":"Eric","year":"2011","journal-title":"Nat Rev Drug Discov"},{"issue":"7618","key":"10.1016\/j.nic.2024.12.002_bib4","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease","volume":"537","author":"Jeff","year":"2016","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.nic.2024.12.002_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N\u00a0Engl J Med"},{"issue":"18","key":"10.1016\/j.nic.2024.12.002_bib6","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","article-title":"Donanemab in early Alzheimer\u2019s disease","volume":"384","author":"Mintun","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.nic.2024.12.002_bib7","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.nic.2024.12.002_bib8","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/WAD.0b013e3181c53b00","article-title":"A\u00a0single ascending dose study of bapineuzumab in patients with Alzheimer disease","volume":"24","author":"Black","year":"2010","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"24","key":"10.1016\/j.nic.2024.12.002_bib9","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1212\/WNL.0b013e3181c67808","article-title":"A\u00a0phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease","volume":"73","author":"Salloway","year":"2009","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.nic.2024.12.002_bib10","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1474-4422(12)70015-7","article-title":"Amyloid-related imaging abnormalities in patients with Alzheimer\u2019s disease treated with bapineuzumab: a retrospective analysis","volume":"11","author":"Reisa","year":"2012","journal-title":"Lancet Neurol"},{"issue":"10","key":"10.1016\/j.nic.2024.12.002_bib11","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.3174\/ajnr.A3500","article-title":"MR imaging features of amyloid-related imaging abnormalities","volume":"34","author":"Barakos","year":"2013","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/j.nic.2024.12.002_bib12","doi-asserted-by":"crossref","DOI":"10.14283\/jpad.2022.21","article-title":"Detection and management of amyloid-related imaging abnormalities in patients with Alzheimer\u2019s disease treated with anti-amyloid beta therapy","author":"Barakos","year":"2022","journal-title":"J\u00a0Prev Alzheimers Dis"},{"key":"10.1016\/j.nic.2024.12.002_bib13","doi-asserted-by":"crossref","DOI":"10.3174\/ajnr.A7586","article-title":"Amyloid-related imaging abnormalities with emerging alzheimer disease therapeutics: detection and reporting recommendations for clinical practice","author":"Cogswell","year":"2022","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"10.1016\/j.nic.2024.12.002_bib14","doi-asserted-by":"crossref","first-page":"e12377","DOI":"10.1002\/trc2.12377","article-title":"ARIA in patients treated with lecanemab (BAN2401) in a phase 2 study in early Alzheimer\u2019s disease","volume":"9","author":"Honig","year":"2023","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.nic.2024.12.002_bib15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.dadm.2016.02.004","article-title":"Amyloid-related imaging abnormalities from trials of solanezumab for Alzheimer\u2019s disease","volume":"2","author":"Carlson","year":"2016","journal-title":"Alzheimer's Dementia (Amst): Diagnosis, Assessment & Disease Monitoring"},{"issue":"4","key":"10.1016\/j.nic.2024.12.002_bib16","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.3233\/JAD-180675","article-title":"Clinical evaluation of amyloid-related imaging abnormalities in bapineuzumab phase III studies","volume":"66","author":"Robert","year":"2018","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.nic.2024.12.002_bib17","article-title":"Amyloid-related imaging abnormalities in 2 phase 3 studies evaluating aducanumab in patients with early alzheimer disease","author":"Stephen","year":"2021","journal-title":"JAMA Neurol"},{"issue":"3","key":"10.1016\/j.nic.2024.12.002_bib18","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0002-9440(10)65616-7","article-title":"Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer\u2019s disease","volume":"153","author":"Weller","year":"1998","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.nic.2024.12.002_bib19","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1750-3639.2008.00133.x","article-title":"Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer\u2019s disease","volume":"18","author":"Weller","year":"2008","journal-title":"Brain Pathol"},{"issue":"147","key":"10.1016\/j.nic.2024.12.002_bib20","doi-asserted-by":"crossref","first-page":"147ra111","DOI":"10.1126\/scitranslmed.3003748","article-title":"A\u00a0paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2","volume":"4","author":"Iliff","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.nic.2024.12.002_bib21","doi-asserted-by":"crossref","first-page":"e40070","DOI":"10.7554\/eLife.40070","article-title":"Aquaporin-4-dependent glymphatic solute transport in the rodent brain","volume":"7","author":"Mestre","year":"2018","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.nic.2024.12.002_bib22","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41582-019-0281-2","article-title":"Cerebral amyloid angiopathy and Alzheimer disease \u2014 one peptide, two pathways","volume":"16","author":"Greenberg","year":"2020","journal-title":"Nat Rev Neurol"},{"issue":"Pt 12","key":"10.1016\/j.nic.2024.12.002_bib23","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1093\/brain\/awn261","article-title":"Consequence of Abeta immunization on the vasculature of human Alzheimer\u2019s disease brain","volume":"131","author":"Boche","year":"2008","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.nic.2024.12.002_bib24","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/ana.23857","article-title":"Anti-amyloid \u03b2 autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies","volume":"73","author":"Fabrizio","year":"2013","journal-title":"Ann Neurol"},{"issue":"17","key":"10.1016\/j.nic.2024.12.002_bib25","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1212\/01.wnl.0000260066.98681.2e","article-title":"Course of cerebral amyloid angiopathy-related inflammation","volume":"68","author":"Kinnecom","year":"2007","journal-title":"Neurology"},{"issue":"18","key":"10.1016\/j.nic.2024.12.002_bib26","first-page":"e1809","article-title":"Spontaneous ARIA-like events in cerebral amyloid angiopathy\u2013related inflammation: a multicenter prospective longitudinal cohort study","volume":"97","author":"Laura","year":"2021","journal-title":"Neurology"},{"issue":"5S","key":"10.1016\/j.nic.2024.12.002_bib27","first-page":"S105","article-title":"Vascular alterations in PDAPP mice after anti-A\u03b2 immunotherapy: implications for amyloid-related imaging abnormalities","volume":"9","author":"Wagner","year":"2013","journal-title":"Alzheimer's Dementia"},{"issue":"2","key":"10.1016\/j.nic.2024.12.002_bib28","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3390\/ijms25020817","article-title":"The importance of complement-mediated immune signaling in Alzheimer\u2019s disease pathogenesis","volume":"25","author":"Batista","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.nic.2024.12.002_bib29","first-page":"e1265","article-title":"Association of microglial activation with spontaneous ARIA-E and CSF levels of anti-A\u03b2 autoantibodies","volume":"99","author":"Fabrizio","year":"2022","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.nic.2024.12.002_bib30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13024-023-00649-w","article-title":"Amyloid-\u03b2 (A\u03b2) immunotherapy induced microhemorrhages are associated with activated perivascular macrophages and peripheral monocyte recruitment in Alzheimer\u2019s disease mice","volume":"18","author":"Taylor","year":"2023","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.nic.2024.12.002_bib33","doi-asserted-by":"crossref","DOI":"10.14283\/jpad.2022.34","article-title":"Aducanumab: appropriate use recommendations update","author":"Cummings","year":"2022","journal-title":"J\u00a0Prev Alzheimers Dis"},{"key":"10.1016\/j.nic.2024.12.002_bib34","doi-asserted-by":"crossref","DOI":"10.14283\/jpad.2023.30","article-title":"Lecanemab: appropriate use recommendations","author":"Cummings","year":"2023","journal-title":"J\u00a0Prev Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.nic.2024.12.002_bib35","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1148\/radiol.2211001712","article-title":"Suppression of cerebrospinal fluid and blood flow artifacts in FLAIR MR imaging with a single-slab three-dimensional pulse sequence: initial experience","volume":"221","author":"Kallmes","year":"2001","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.nic.2024.12.002_bib36","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3174\/ajnr.A1355","article-title":"MR imaging detection of cerebral microbleeds: effect of susceptibility-weighted imaging, section thickness, and field strength","volume":"30","author":"Nandigam","year":"2009","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"10.1016\/j.nic.2024.12.002_bib37","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/ana.10810","article-title":"Clinical manifestations of cerebral amyloid angiopathy-related inflammation","volume":"55","author":"Eng","year":"2004","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.nic.2024.12.002_bib38","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.3174\/ajnr.A0928","article-title":"Posterior reversible encephalopathy syndrome, Part 1: fundamental imaging and clinical features","volume":"29","author":"Bartynski","year":"2008","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/j.nic.2024.12.002_bib39","first-page":"awad188","article-title":"Amyloid-related imaging abnormalities (ARIA): radiological, biological and clinical characteristics","author":"Harald","year":"2023","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.nic.2024.12.002_bib40","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1056\/NEJMc2215148","article-title":"Multiple cerebral hemorrhages in a patient receiving lecanemab and treated with t-PA for stroke","volume":"388","author":"Reish","year":"2023","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.nic.2024.12.002_bib41","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/RLI.0000000000000723","article-title":"A\u00a0comprehensive view on MRI techniques for imaging blood-brain barrier integrity","volume":"56","author":"Elschot","year":"2021","journal-title":"Invest Radiol"},{"issue":"4","key":"10.1016\/j.nic.2024.12.002_bib42","doi-asserted-by":"crossref","first-page":"229","DOI":"10.13104\/imri.2022.26.4.229","article-title":"Arterial spin labelling-based blood-brain barrier assessment and its applications","volume":"26","author":"Yiran","year":"2022","journal-title":"Investig Magn Reson Imaging"},{"issue":"3\u20134","key":"10.1016\/j.nic.2024.12.002_bib43","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000375153","article-title":"Cerebral perivascular spaces visible on magnetic resonance imaging: development of a qualitative rating scale and its observer reliability","volume":"39","author":"Potter","year":"2015","journal-title":"Cerebrovasc Dis"},{"issue":"1","key":"10.1016\/j.nic.2024.12.002_bib44","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/jmri.28369","article-title":"Automated methods for detecting and quantitation of enlarged perivascular spaces on MRI","volume":"57","author":"Jasmine","year":"2023","journal-title":"J\u00a0Magn Reson Imag"},{"issue":"4","key":"10.1016\/j.nic.2024.12.002_bib45","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s11604-017-0617-z","article-title":"Evaluation of glymphatic system activity with the diffusion MR technique: diffusion tensor image analysis along the perivascular space (DTI-ALPS) in Alzheimer\u2019s disease cases","volume":"35","author":"Toshiaki","year":"2017","journal-title":"Jpn J Radiol"},{"issue":"2","key":"10.1016\/j.nic.2024.12.002_bib46","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00234-023-03270-2","article-title":"Glymphatic imaging: a critical look at the\u00a0DTI-ALPS index","volume":"66","author":"Geir","year":"2024","journal-title":"Neuroradiology"}],"container-title":["Neuroimaging Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052514924001047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052514924001047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T14:37:04Z","timestamp":1751380624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1052514924001047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1052514924001047"],"URL":"https:\/\/doi.org\/10.1016\/j.nic.2024.12.002","relation":{},"ISSN":["1052-5149"],"issn-type":[{"value":"1052-5149","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered Clearance and Amyloid-Related Imaging Abnormalities","name":"articletitle","label":"Article Title"},{"value":"Neuroimaging Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nic.2024.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}